The human body is a master of concealment. For years, sometimes decades, it can sustain processes that gradually erode its resilience without issuing a single cry for help. We wake each morning with a sense of well-being that persuades us that the absence of pain is evidence of health. It is not. Health is not a static condition but a dynamic equilibrium, and disease is rarely a sudden event. More often, it is the culmination of biological changes that have been unfolding long before symptoms bring them to our attention.
A Storm Forming in a Clear Sky: One of the most common misconceptions is that a disease begins on the day a physician gives it a name. In reality, many diseases develop silently for years before they cross the threshold at which they become clinically recognizable.
Consider Alzheimer’s disease. The accumulation of amyloid-β plaques in the brain, a protein that clumps together and interferes with normal neuronal function, can begin many years, often one to two decades, before the first noticeable cognitive symptoms. During that long preclinical period, pathological changes may be advancing while everyday life appears entirely normal. The storm is already forming, even though the horizon still looks serene.
Type 2 diabetes follows a similar pattern. Long before blood glucose reaches the diagnostic threshold, the body may have endured years of metabolic stress. Tissues become progressively less responsive to insulin, while the pancreas increases insulin secretion to compensate and keep glucose levels within the normal range. By the time a blood test raises the alarm, the underlying metabolic disturbance may have been developing for years.
The heart, too, can remain remarkably silent. Autopsy studies conducted across several decades and populations, among them a well-known series performed on young soldiers who died in combat, revealed that many already had evidence of coronary atherosclerosis despite being young and apparently healthy. This finding, confirmed since in civilian populations of different countries, showed that the disease had begun long before symptoms could announce its presence. Decades may pass between the earliest biological changes and the first clinical warning.
It is a language we have often failed to learn to interpret.
The Trap of Red Lines: Here lies one of medicine’s great tensions, our dependence on diagnostic labels. The thresholds used to distinguish health from disease are indispensable for clinical practice, yet many of them represent points along a biological continuum rather than abrupt boundaries in nature.
Take blood glucose, as an example that illustrates the point well. A fasting glucose level of 99 mg/dL falls within the normal range, whereas 100 mg/dL meets the laboratory criterion for impaired fasting glucose, commonly classified as prediabetes. Does anything dramatic change in our cells because of that single milligram? Of course not. What changes immediately is the category, not the underlying biology.
This threshold effect can create a false sense of reassurance. A value just below a diagnostic cut-off may be interpreted as a green light, even when the broader pattern of metabolic health deserves attention.
Biology does not work in categories as neatly as medicine sometimes needs it to.
Listening to the Whisper: The good news is that many of these processes leave measurable traces, and modern medicine is increasingly capable of detecting them. The earlier a clinically meaningful change is recognized, the greater the opportunity to modify the factors that are driving it. Blood pressure, lipid profiles, glucose regulation, inflammatory markers and, in appropriate contexts, heart-rate variability, a measure of the tiny fluctuations between consecutive heartbeats that reflects how well the nervous system regulates the heart, can provide valuable information about physiological function.
They do not predict the future with certainty. But taken together, interpreted in context and followed over time, they can reveal patterns that a single measurement may conceal. They give us an opportunity to adjust our course before a biological disturbance becomes an established disease.
This opportunity, however, carries its own price. Listening too closely to the body’s whisper can also generate noise. Detecting a subtle change years before any disease might develop does not always translate into a clear course of action, and it can produce anxiety, unnecessary testing or treatments whose benefit is not yet established. Alzheimer’s disease is a case in point, since we are now able to detect amyloid accumulation long before any cognitive symptom appears, yet medicine still does not have a reliable way to prevent the disease in a person identified this way. Early detection is valuable, as a rule, but it is not automatically synonymous with benefit. The whisper deserves attention, not alarm, and knowing the difference is itself a form of medical wisdom.
The Twin Living in the Data: Imagine projecting your biology into a digital mirror, an evolving computational representation built from longitudinal health data such as laboratory measurements, physiological signals, medical history and, where scientifically validated and appropriately available, genomic or microbiome information. A model that does not feel, but can reveal patterns. This is the promise of a digital twin in medicine.
The concept originated in engineering, where digital representations of physical systems are used to monitor performance, anticipate failures and test scenarios. It is now being explored in medicine, where the ambition is to move from isolated measurements towards a more dynamic representation of an individual’s health.
A medical digital twin could integrate repeated observations and identify subtle changes that might appear insignificant when viewed separately but become meaningful when considered together. Its greatest potential lies not in replacing the physician or predicting an individual’s destiny, but in helping clinicians understand trajectories, personalize interventions and explore possible outcomes before decisions are made.
The idea of a virtual double that absorbs information in the digital realm to help protect its physical counterpart resonates with a deeply human desire, to foresee danger before it becomes suffering.
Yet this technology also casts shadows that deserve our attention. Who owns our most intimate biological data? Who controls how it is used? How do we prevent increasingly sophisticated medicine from becoming accessible only to those who can afford it? These questions must be addressed as carefully as the technology itself is developed.
Caring for the body before a diagnosis appears is not anxiety. It is a more mature way of inhabiting our own lives, provided that this vigilance is guided by evidence and proportion rather than by fear.
The body’s silence is not always a sign of peace. Sometimes it simply means that we have not yet learned to listen.
Its whispers may be subtle, but learning to hear them, and knowing when to act on them, can give us something extraordinarily valuable, time.
Nullius in verba